What is NDC 50090-8037?

50090-8037 is the product NDC for etodolac, Etodolac 300 mg/1 capsule, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for etodolac?

100 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

etodolac NDC 50090-8037 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-8037Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-8037Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-8037-1	50090803701	21 CAPSULE in 1 BOTTLE (50090-8037-1)Marketed from Aug 25, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): etodolac
Generic name (nonproprietary): etodolac
Active ingredients: Etodolac — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205448
Marketing start: Feb 6, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 50090-8037_a5523ef4-512f-4622-89cb-6951d1fa2aa2SPL ID a5523ef4-512f-4622-89cb-6951d1fa2aa2SPL set ID 1e04a6b7-a671-4999-ab03-aa1a243aac03RxCUI 197685UNII 2M36281008
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090803701 followed by a unit qualifier and the quantity

Package 50090-8037-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 28, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac capsules and other treatment options before deciding to use etodolac capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac capsules are indicated: • For acute and long-term use in the management of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis • For the management of acute pain

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-8037

What is NDC 50090-8037?: 50090-8037 is the product NDC for etodolac, Etodolac 300 mg/1 capsule, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: etodolac.
What is the active ingredient?: Etodolac.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for etodolac?: 100 other product NDCs are listed under this name. See all etodolac NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other etodolac NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-461	59651-0461-01
Etodolac	Etodolac 500 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-462	59651-0462-01
etodolac	Etodolac 400 mg/1	TabletOral	Ipca Laboratories Limited	83980-029	83980-0029-0183980-0029-1083980-0029-13
etodolac	Etodolac 500 mg/1	TabletOral	Ipca Laboratories Limited	83980-030	83980-0030-0183980-0030-0583980-0030-13
etodolac	Etodolac 200 mg/1	CapsuleOral	Ipca Laboratories Limited	83980-031	83980-0031-0183980-0031-0583980-0031-13
etodolac	Etodolac 300 mg/1	CapsuleOral	Ipca Laboratories Limited	83980-032	83980-0032-0183980-0032-0583980-0032-13
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4542	70518-4542-00
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Advanced Rx of Tennessee, LLC	80425-0551	80425-0551-01
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8846	68788-8846-0168788-8846-0268788-8846-03+2 more
Etodolac	Etodolac 500 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4291	70518-4291-00

All 101 etodolac NDCs

Other NDCs under ANDA 205448

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205448
Product	Strength	Form · route	Labeler	Product NDC
etodolac	Etodolac 200 mg/1	CapsuleOral	Ipca Laboratories Limited	83980-031
etodolac	Etodolac 300 mg/1	CapsuleOral	Ipca Laboratories Limited	83980-032